GR1004109B - Injectable solutions of paracetamol carisoprodol and citric orphenadrine - Google Patents

Injectable solutions of paracetamol carisoprodol and citric orphenadrine

Info

Publication number
GR1004109B
GR1004109B GR990100107A GR990100107A GR1004109B GR 1004109 B GR1004109 B GR 1004109B GR 990100107 A GR990100107 A GR 990100107A GR 990100107 A GR990100107 A GR 990100107A GR 1004109 B GR1004109 B GR 1004109B
Authority
GR
Greece
Prior art keywords
orphenadrine
carisoprodol
citric
paracetamol
injectable solutions
Prior art date
Application number
GR990100107A
Other languages
Greek (el)
Other versions
GR990100107A (en
Inventor
Original Assignee
Uni Pharma ����� ������ ������������ ���������� ����
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Pharma ����� ������ ������������ ���������� ���� filed Critical Uni Pharma ����� ������ ������������ ���������� ����
Publication of GR990100107A publication Critical patent/GR990100107A/en
Publication of GR1004109B publication Critical patent/GR1004109B/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

njectable solution containing for active ingredients paracetamol and muscle-relaxing substances, such as the citric orphenadrine and carisoprodol where, in both cases, the diluters are ethanol, water and glucerol formal.The above mentioned solutioncontains also Cl lidocaine, EDTA, sodium metabisulfite, and sodium dibasic phosphate meant to regylate the pH of the solution.
GR990100107A 1999-04-01 1999-04-01 Injectable solutions of paracetamol carisoprodol and citric orphenadrine GR1004109B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR99100107 1999-04-01

Publications (2)

Publication Number Publication Date
GR990100107A GR990100107A (en) 2000-12-29
GR1004109B true GR1004109B (en) 2003-01-16

Family

ID=10943782

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990100107A GR1004109B (en) 1999-04-01 1999-04-01 Injectable solutions of paracetamol carisoprodol and citric orphenadrine

Country Status (1)

Country Link
GR (1) GR1004109B (en)

Also Published As

Publication number Publication date
GR990100107A (en) 2000-12-29

Similar Documents

Publication Publication Date Title
FR2714830B1 (en) Composition containing nucleic acids, preparation and uses.
TR199801360T2 (en) New substituted imidazole compounds.
NO971889L (en) Compounds and compositions for delivery of active agents
DE69925276D1 (en) SUBSTANCES AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
TR200103428T2 (en) IMPDH enzyme inhibitors.
BR9910251A (en) Hematopoietic stimulation
ATE286053T1 (en) NAPHTHYRIDINONE FOR INHIBITING CELL PRODUCTION CAUSED BY PROTEIN TYROSINE KINASE AND CELL CYCLE KINASE
DK0980263T3 (en) Combination product combining a nucleic acid with a substance that dissolves the extracellular matrix for gene therapy
ATE91901T1 (en) VEHICLE FOR ADMINISTRATION OF INTERFERON.
DK0643775T3 (en) Quinone derivatives for enhancing cell bioenergy
ATE370730T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING CHELATING/SEQUESTING AGENTS AND THEIR DERMATOLOGICAL USE
HUP0001937A2 (en) Compounds, preparation and use for transferring nucleic acids into cells
ES2249058T3 (en) PRESERVATION FACTORS OF PROGENITING CELLS AND RELATED METHODS AND PRODUCTS.
DE59009945D1 (en) AGENT FOR INHIBITING HIV PROTEASES.
ATE316132T1 (en) LIQUID DETERGENT WITH IMPROVED ALPHA-AMYLASE ENZYME STABILITY
SE9803272D0 (en) A drug for cell regeneration
TR200103125T2 (en) Anticonvulsant derivatives for use in improving autism.
GR1004109B (en) Injectable solutions of paracetamol carisoprodol and citric orphenadrine
ME00088B (en) Paracetamol and drotaverine containing composition
DE60028750D1 (en) USE OF TAGATOSIS TO IMPROVE IMPORTANT BLOOD FACTORS
ATE431748T1 (en) FORMULATIONS CONTAINING DEXTRIN POLYMERS IN COMBINATION WITH SUGAR FOR THE ADMINISTRATION OF NUCLEIC ACIDS
DK162440C (en) PYRAZINDIAZOHYDROXIDE COMPOUNDS
HUP0102455A2 (en) Novel nucleic acid transfer agents, compositions containing same and uses
ES2150891T1 (en) METHOD FOR THE INDUCTION OF APOPTODIC CELL DEATH IN MALIGNANT CELLS THROUGH THE REDUCTION OF THE RELATION OF RB TO APOPTOSIS INDUCING PROTEINS.
JPS57131723A (en) Enzymatic activity inhibiting agent

Legal Events

Date Code Title Description
PG Patent granted